No Data
Shareholder The Cigna Group and The Cigna Group Xinshi have cumulatively reduced their shareholding by 1.8424 million shares.
Huibei New Materials (301555.SZ) announced that the company recently received a notice regarding shares issued by The Cigna Group New Materials and Cigna Xingshan.
Huibo New Materials (301555.SZ): Plans to use part of the raised funds and its own funds to increase capital in its subsidiary to implement the fundraising project.
On February 28, Glonghui reported that Huibai New Materials (301555.SZ) announced that it would hold the seventh meeting of the fourth Board of Directors and the sixth meeting of the fourth Supervisory Board on February 27, 2025, to review and approve the "Proposal on Using Part of the Raised Funds and Own Funds to Increase Capital in Subsidiaries to Implement Fundraising Projects." The company agreed to use part of the raised funds and its own funds to increase the capital of its wholly-owned subsidiary Huibai New Materials Technology (Zhuhai) Co., Ltd. (referred to as "Zhuhai Huibai") by 57 million yuan to implement Zhuhai Huibai's "New Construction of 0.082 million tons of new electronic special materials production project," which.
Huibai New Materials (301555.SZ): plans to postpone the "Huibai New Materials R&D Headquarters Project" until March 2026.
Gelonghui, February 28 - Huibai New Materials (301555.SZ) announced that the company held the seventh meeting of the fourth Board of Directors and the sixth meeting of the fourth Supervisory Board on February 27, 2025, and approved the proposal regarding the延期 of certain fundraising projects, agreeing to extend the planned usable status of the fundraising project "Huibai New Materials R&D Headquarters Project" to March 2026, provided that there are no changes in the implementation entity, construction content, use of raised funds, and investment project scale. If the project conditions are met during the process, it will be promptly concluded.
Huibai New Materials (301555.SZ) issued a profit warning, expecting a net income of 8.5 million to 11 million yuan for the year 2024, a year-on-year decline of 80.84% to 85.19%.
Huibai New Materials (301555.SZ) announced the performance forecast for the 2024 fiscal year, expecting to belong to the listed company shareholders...
Huibai New Materials: 2024 performance forecast
Hui Bai New Materials (301555.SZ): The cigna group New Materials Industry Investment Fund and its concerted parties plan to collectively reduce their shareholding by no more than 3%.
On November 8th, Ge Longhui announced that Shenzhen The Cigna Group New Materials Industry Investment Fund Enterprise (limited partnership) is a shareholder of Huibai New Materials Technology (Shanghai) Co., Ltd. (referred to as the "Company"), holding 4,991,995 shares of the company's stock (accounting for 5.41% of the total share capital of the company), and its concerted actioner, Shenzhen The Cigna Group Xinshan Investment Enterprise (limited partnership) holds 280,000 shares of the company's stock (accounting for 0.30% of the total share capital of the company). The above shareholders plan to trade through centralized bidding 15 trading days after the announcement disclosure date within 3 months.
